Treatment of Advanced Non–Small-Cell Lung Cancer With Two-Drug Combinations-Reference-Cited by-同舟云学术

Treatment of Advanced Non–Small-Cell Lung Cancer With Two-Drug Combinations

Published:2002-09-01 Issue:17 Volume:20 Page:3565-3567
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Bunn Paul A.¹

Affiliation:

1. University of Colorado Cancer Center, Denver, CO

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2002.20.17.3565

Reference28 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

2. Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

3. The economics of lung cancer management in Canada

4. Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial

5. Van Meerbeeck JP, Smit EF, Lianes P, et al: A EORTC randomized phase III trial of three chemotherapy regimens in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 20: 308a,2001 (abstr 1228)

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymers in the co-delivery of siRNA and anticancer drugs to treat multidrug-resistant tumors;Journal of Pharmaceutical Investigation;2017-01

2. Palliative Therapy;Encyclopedia of Cancer;2017

3. Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT);PLOS ONE;2016-03-31

4. Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease;Cochrane Database of Systematic Reviews;2012-04-18

5. Chemotherapy options for Advanced Non-small cell Lung Cancer;EMERG CANCER THER;2012